Cat. No. | Product name | CAS No. |
DCC1874 |
Dt-061
Novel potent and orally active activator of PP2A |
1809427-19-7 |
DCC1875 |
Dt2216nc
Negative control for DT2216 |
|
DCC1876 |
Dtagv-1
Potent and selective degrader of mutant FKBP12F36V fusion proteins |
|
DCC1877 |
Du-34569 Maleate
Antiviral agent against influenza A, parainfluenza Sendai, coxsackie A21, and rhinovirus |
34522-38-8 |
DCC1878 |
Duocarmycin A
Irreversible DNA minor groove binding alkylating agent, disrupting the nucleic acid architecture and leading to tumor cell death |
118292-34-5 |
DCC1879 |
Dutomycin
Anthracycline antibiotic from Streptomyces |
146663-67-4 |
DCC1880 |
Dv-7028
Selective 5-HT2A receptor antagonist |
133364-63-3 |
DCC1881 |
Dv-7028 Hydrochloride
Potent and selective 5-HT 2A receptor antagonist |
133364-62-2 |
DCC1882 |
Dw10075
Novel potent and highly selective inhibitor of VEGFR, exhibiting antitumor activities both in vitro and in vivo. |
1804982-31-7 |
DCC1883 |
Dw-1350
Novel and potent leukotriene B(4) receptor antagonist |
491577-61-8 |
DCC1884 |
Dwn-723-23
Novel Hsp70 agonist, showing no cellular toxicity and induced cellular stress response pathways |
|
DCC1885 |
Dx2-hsp70 Inhibitor-1
Novel allosteric inhibitor of the tumor-promoting interaction between the oncogenic factor AIMP2-DX2 and HSP70 |
125105-17-1 |
DCC1886 |
Dx-52-1
Antitumor antibiotic |
96251-59-1 |
DCC1887 |
Dy3002
Novel Selective and Potent EGFR Inhibitor, Overcoming T790M-Mediated Resistance in Non-Small Cell Lung Cancer |
2020015-37-4 |
DCC1888 |
Dy428174
Novel potent Inhibitor of PI3Kalpha |
1202041-71-1 |
DCC1889 |
E09241
Novel OPG/RANKL upregulator, increasing OPG expression without affecting RANKL expression, promoting osteoblast differentiation while inhibiting osteoclast differentiation, regulating OPG expression through canonical Wnt/β-catenin signaling |
1043110-13-9 |
DCC1890 |
e2012-bpyne
γ-Secretase modulator (GSM) photoaffinity probe, revealing distinct allosteric binding sites on presenilin |
1430800-80-8 |
DCC1891 |
E235-1756
Potent Activator of P53-Independent Cellular Senescence |
891894-69-2 |
DCC1892 |
E3-ligase Degrader 10
Novel XIAP BIR2 domain-binding degrader of E3 ubiquitin ligases |
|
DCC1893 |
E-5842 Citrate
Sigma1 receptor ligand and potential atypical antipsychotic |
220120-14-9 |
DCC1894 |
Ea-b3a
Novel degrader of GST-α and GST-α-EGFP fusion proteins as well as endogenous GST-π in cells and lysates |
|
DCC1895 |
Ebi-13a
Highly potent and selective activator of isozymes CA-VA and CA-VII |
147596-31-4 |